Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Food Ingredients Chin... Food Ingredients China
Not Confirmed
Not Confirmed
17-19 March, 2026
RNA Leaders EuropeRNA Leaders Europe
Not Confirmed
Not Confirmed
17-19 March, 2026
Rare Disease SummitRare Disease Summit
Not Confirmed
Not Confirmed
17-19 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Food Ingredients Chin... Food Ingredients China
Industry Trade Show
Not Confirmed
17-19 March, 2026
RNA Leaders EuropeRNA Leaders Europe
Industry Trade Show
Not Confirmed
17-19 March, 2026
Rare Disease SummitRare Disease Summit
Industry Trade Show
Not Confirmed
17-19 March, 2026
Digital content

25 Feb 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260225014331/en/Arcus-Biosciences-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-a-Pipeline-Update

23 Feb 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260223145191/en/Arcus-Presents-New-Data-for-its-HIF-2a-Inhibitor-Casdatifan-Which-Showed-Progression-Free-Survival-Beyond-One-Year-in-Late-Line-Kidney-Cancer

11 Feb 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260211207137/en/Arcus-Biosciences-to-Host-Conference-Call-to-Discuss-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Pipeline-Updates

26 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260126311223/en/Arcus-Biosciences-Announces-New-Employment-Inducement-Grants

07 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260107233571/en/Arcus-Outlines-2026-Plans-for-Casdatifan-its-Potential-Best-in-Class-HIF-2a-Inhibitor-and-its-Inflammation-Programs

18 Dec 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251218075951/en/Arcus-Biosciences-to-Participate-in-the-44th-Annual-J.P.-Morgan-Healthcare-Conference
ABOUT THIS PAGE